Analysis and reporting of adverse drug reactions at a tertiary care teaching hospitalFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 29 November 2018

References

• K.M.R.JayeshS.KajalA.K.SrivastavPharmacovigilance: a review articleInnov J Med Sci4201667
   Google Scholar
• S.MaysaF.DoaaA.F.RanaPharmacist’s knowledge, practice, and attitudes toward Pharmacovigilance and adverse drug reactions reporting processSaudi Pharma J232015147153
   Web of Science ®Google Scholar
• J.L.RatanL.MangalaD.SukirtiA study on adverse drug reactions in a tertiary care hospital of northeast IndiaAlex J Med532017151156
   Web of Science ®Google Scholar
• G.SnehaN.SowmyaK.G.PremAn observational prospective study on prevalence and monitoring of adverse drug reactions in tertiary care teaching hospitalBJPR11201619
   Google Scholar
• B.V.MariliaM.CinthiaM.S.S.CatarinaAdverse drugs reactions and quality deviations monitored by spontaneous reportsSaudi Pharma J232015130137
   Web of Science ®Google Scholar
• T.NehaI.MohdG.SyedazizullahR.AshokM.MohdDermatological adverse drug reactions in tertiary care hospitalIJPSR62015816824
   Google Scholar
• O.A.PeterK.E.AbiodunO.A.EyoI.ChukuIncidence of adverse drug reactions in patients on antiretroviral therapy: a study of pharmaceutical care in HIV interventions in a tertiary health facility in southern NigeriaRes Hum Soc Sci62016103107
   Google Scholar
• Safety of Medicines In Public Health Programmes: Pharmacovigilance an essential tool, World Health Organization 2006. Available from: <http://www.who.int/medicines/areas/quality_safety/safety_efficacy/Pharmacovigilance_B.pdf?ua=1> [Accessed 18 May 2016].
   Google Scholar
• H.SinghN.DulhaniB.N.KumarP.SinghP.TewariK.NayakA Pharmacovigilance study in medicine department of tertiary care hospital in Chhattisgarh (Jagdalpur), IndiaJ Young Pharm2201095100
   Google Scholar
• C.D.EmmaF.G.ChristopherT.StephenR.W.PaulaR.M.DavidP.MunirAdverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodesPLoS ONE42009e4439
   Web of Science ®Google Scholar
• V.KalaiselvanP.ThotaG.N.SinghPharmacovigilance programme of India: recent developments and future perspectivesInd J Pharmacol482016624628
   Google Scholar
• World Health Organization: Countries. Available from: http://www.who.int/countries/en/ [accessed 18 May 2016].
   Google Scholar
• Pharmacovigilance Programme of India (PvPI) Performance Report 2015-16. Available from: http://www.ipc.gov.in/PvPI/pub/Pharmacovigilance%20Programme%20of%20India%20Annual%20performance%20Report%202015-2016.pdf [accessed 19 May 2017].
   Google Scholar
• Indian Pharmacopoeia Commission (IPC) Guidance Document for Spontaneous Adverse Drug Reaction Reporting. Available from: http://ipc.nic.in/writereaddata/mainlinkFile/File268.pdf; 2014 [accessed 13 December 2017].
   Google Scholar
• R.SrinivasanG.RamyaAdverse drug reaction-causality assessmentIJRPC12011606612
   Google Scholar
• T.B.AgbabiakaJ.SavovicE.ErnstMethods for causality assessment of adverse drug reactions: a systematic reviewDrug Saf3120082137
   PubMed Web of Science ®Google Scholar
• A.F.MacedoF.B.MarquesC.F.RibeiroF.TexeiraCausality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panelPharmacoepidemiol Drug Saf142005885890
   PubMed Web of Science ®Google Scholar
• G.LagierM.VincensA.CastotImputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoidTherapie381983303318
   PubMed Web of Science ®Google Scholar
• The use of the WHO-UMC system for standardized case causality assessment. Available from: http://www.who-umc.org/media/2768/standardised-case-causality-assessment.pdf [accessed 13 December 2017].
   Google Scholar
• H.S.RehanD.ChopraA.KakkarPhysician's guide to Pharmacovigilance: terminology and causality assessmentEur J InterMed20200938
   PubMed Web of Science ®Google Scholar
• L.R.AsawariP.PalakP.ChintanP.AtmaramPreventability, predictability, and seriousness of adverse drug reactions amongst medicine inpatients in a teaching hospital: a prospective observational studyInt J Pharma Chem Sci1201212931299
   Google Scholar
• T.M.VijayakumarM.D.DhanarajuDescription of adverse drug reactions in a multi-specialty teaching hospitalInt J Integr Med1201316
   Google Scholar
• R.KiranS.DivyaN.PrathibaP.BhanuMonitoring and analysis of drug reactions in a private tertiary care teaching hospitalAsian J Pharm Clin Res82015335337
   Google Scholar
• R.SangeethaR.JamunaP.KalaPattern of adverse drug reactions in a tertiary care teaching hospital: a cross-sectional studyAsian J Pharm Clin Res.102017170173
   Google Scholar
• G.A.de.A.L.MarciaM.B.P.SandraG.D.JoseG.M.ValeriaC.S.P.MariaAdverse drug reaction monitoring: support for Pharmacovigilance at a tertiary care hospital in northern BrazilBMC Pharmacol Toxicol1420135
   Web of Science ®Google Scholar
• G.PankajU.AadityaAdverse drug reaction reporting and Pharmacovigilance: knowledge, attitudes, and perceptions amongst resident doctorsJ Pharma Sci Res3201110641069
   Google Scholar
• M.ShammaC.DilipM.AjmalA prospective study on adverse drug reactions of antibiotics in a tertiary care hospitalSaudi Pharma J222014303308
   Web of Science ®Google Scholar
• S.PalanisamyK.G.ArulR.AiyaluA study on adverse drug reactions at a tertiary care teaching hospitalInt J Pharm Teach Pract2201196101
   Google Scholar
• P.SivanandyK.S.G.ArulR.AiyaluA study on assessment, monitoring, and reporting of adverse drug reactions in Indian hospitalAsian J Pharm Clin Res42011112116
   Google Scholar
• M.M.MohamedL.AbdelA.A.W.BaselKnowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi ArabiaSaudi Pharma J232015154161
   Web of Science ®Google Scholar